LeMaitre Vascular - 18 Year Stock Price History | LMAT

Historical daily share price chart and data for LeMaitre Vascular since 2006 adjusted for splits and dividends. The latest closing stock price for LeMaitre Vascular as of April 26, 2024 is 65.46.
  • The all-time high LeMaitre Vascular stock closing price was 70.89 on February 28, 2024.
  • The LeMaitre Vascular 52-week high stock price is 74.64, which is 14% above the current share price.
  • The LeMaitre Vascular 52-week low stock price is 44.27, which is 32.4% below the current share price.
  • The average LeMaitre Vascular stock price for the last 52 weeks is 59.45.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
LeMaitre Vascular Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 62.2891 56.5741 70.8897 53.8706 65.4600 15.60%
2023 54.8892 44.8606 67.6941 44.1693 56.6240 24.60%
2022 45.7644 50.3099 55.0010 38.2506 45.4432 -7.39%
2021 50.6390 38.9185 61.6107 38.9185 49.0693 25.12%
2020 29.5677 34.2334 39.9644 20.1755 39.2187 14.08%
2019 28.8064 22.1196 34.6254 21.2307 34.3768 53.77%
2018 31.4219 29.1840 38.5419 20.8146 22.3561 -25.13%
2017 28.2169 23.4869 36.6377 20.3870 29.8592 26.58%
2016 16.0700 14.5690 23.7010 11.5115 23.5893 48.49%
2015 10.3414 7.0978 16.3648 6.6168 15.8859 128.79%
2014 6.8338 7.1288 7.5423 5.9609 6.9435 -2.72%
2013 5.9567 5.0422 7.6801 5.0422 7.1377 42.05%
2012 5.1210 4.9385 5.6900 4.3214 5.0247 -1.35%
2011 5.6541 5.8968 6.4098 4.5427 5.0933 -11.46%
2010 4.8815 4.2314 6.1857 3.7556 5.7524 35.40%
2009 2.7900 1.8183 4.2484 1.6229 4.2484 116.63%
2008 3.0427 5.0981 5.7014 1.5804 1.9611 -62.77%
2007 5.5071 5.1406 6.5001 4.7243 5.2681 3.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.414B $0.193B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.422B 24.34
Stryker (SYK) United States $128.275B 31.81
Boston Scientific (BSX) United States $107.479B 34.23
Medtronic (MDT) Ireland $105.230B 14.90
EssilorLuxottica (ESLOY) France $98.467B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.075B 0.00
Haleon (HLN) United Kingdom $38.356B 30.00
ResMed (RMD) United States $26.979B 25.30
Terumo (TRUMY) Japan $24.775B 34.99
Zimmer Biomet Holdings (ZBH) United States $24.604B 15.84
Baxter (BAX) United States $20.430B 14.90
Koninklijke Philips (PHG) Netherlands $19.242B 15.35
Insulet (PODD) United States $11.496B 60.36
Smith & Nephew SNATS (SNN) United Kingdom $10.440B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $7.860B 23.42
BellRing Brands (BRBR) United States $7.238B 38.92
Lantheus Holdings (LNTH) United States $4.470B 11.54
Haemonetics (HAE) United States $4.452B 22.77
Perrigo (PRGO) Ireland $4.238B 12.12
GN Store Nord (GNNDY) Denmark $3.889B 25.18
Prestige Consumer Healthcare (PBH) United States $3.482B 16.47
Envista Holdings (NVST) United States $3.441B 13.09
QuidelOrtho (QDEL) United States $2.654B 9.63
Neogen (NEOG) United States $2.591B 24.92
Green Thumb Industries (GTBIF) United States $2.482B 78.67
ICU Medical (ICUI) United States $2.303B 17.19
TG Therapeutics (TGTX) United States $2.150B 695.50
Maravai LifeSciences Holdings (MRVI) United States $1.906B 0.00
Owens & Minor (OMI) United States $1.848B 17.74
Agios Pharmaceuticals (AGIO) United States $1.780B 0.00
Verano Holdings (VRNOF) United States $1.617B 0.00
InMode (INMD) Israel $1.429B 7.40
National Vision Holdings (EYE) United States $1.399B 43.58
AdaptHealth (AHCO) United States $1.273B 9.58
Warby Parker (WRBY) United States $1.254B 0.00
AtriCure (ATRC) United States $1.094B 0.00
MacroGenics (MGNX) United States $0.899B 0.00
Canopy Growth (CGC) Canada $0.872B 0.00
BioLife Solutions (BLFS) United States $0.764B 0.00
VAREX IMAGING (VREX) United States $0.686B 14.82
Cresco Labs (CRLBF) United States $0.674B 0.00
Evolus (EOLS) United States $0.664B 0.00
Jin Medical (ZJYL) China $0.608B 0.00
Quanterix (QTRX) United States $0.596B 0.00
Valneva SE (VALN) France $0.526B 0.00
Phibro Animal Health (PAHC) United States $0.504B 10.91
PetIQ (PETQ) United States $0.480B 17.93
TerrAscend (TSNDF) Canada $0.462B 0.00
ZimVie (ZIMV) United States $0.421B 25.80
Biote (BTMD) United States $0.416B 3.96
OraSure Technologies (OSUR) United States $0.402B 6.66
Surmodics (SRDX) United States $0.373B 40.26
Aurora Cannabis (ACB) Canada $0.366B 0.00
Zynex (ZYXI) United States $0.352B 40.52
Viemed Healthcare (VMD) United States $0.310B 30.81
Cerus (CERS) United States $0.308B 0.00
Sanara MedTech (SMTI) United States $0.278B 0.00
TriSalus Life Sciences (TLSI) United States $0.266B 0.00
Utah Medical Products (UTMD) United States $0.238B 14.73
Organigram Holdings (OGI) Canada $0.192B 0.00
Ayr Wellness (AYRWF) United States $0.178B 0.00
Omeros (OMER) United States $0.177B 0.00
Veru (VERU) United States $0.177B 0.00
Capricor Therapeutics (CAPR) United States $0.162B 0.00
High Tide (HITI) Canada $0.161B 0.00
Quipt Home Medical (QIPT) United States $0.156B 0.00
Eagleford Energy (GRUSF) United States $0.141B 70.99
FitLife Brands (FTLF) United States $0.129B 20.74
Jushi Holdings (JUSHF) United States $0.125B 0.00
InterCure (INCR) Israel $0.120B 20.31
Fonar (FONR) United States $0.107B 9.16
MariMed (MRMD) United States $0.100B 0.00
Cellectar Biosciences (CLRB) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
Allurion Technologies (ALUR) United States $0.089B 0.00
Safety Shot (SHOT) United States $0.082B 0.00
Brainsway (BWAY) Israel $0.080B 0.00
Chimerix (CMRX) United States $0.079B 0.00
Zevia PBC (ZVIA) United States $0.059B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.055B 3.59
Apyx Medical (APYX) United States $0.051B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
Cytosorbents (CTSO) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
United-Guardian (UG) United States $0.038B 14.95
Bright Green (BGXX) United States $0.035B 0.00
Modular Medical (MODD) United States $0.033B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
FSD PHARMA (HUGE) Canada $0.019B 0.00
Agape ATP (ATPC) $0.019B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.012B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 74.09
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.008B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00